Fidelis Capital Partners LLC Has $1.30 Million Stock Position in Colgate-Palmolive (NYSE:CL)

Fidelis Capital Partners LLC raised its stake in Colgate-Palmolive (NYSE:CLFree Report) by 69.3% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 12,639 shares of the company’s stock after acquiring an additional 5,175 shares during the quarter. Fidelis Capital Partners LLC’s holdings in Colgate-Palmolive were worth $1,295,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in CL. E Fund Management Hong Kong Co. Ltd. acquired a new stake in shares of Colgate-Palmolive in the second quarter valued at approximately $25,000. Core Wealth Advisors Inc. increased its stake in shares of Colgate-Palmolive by 56.6% in the 4th quarter. Core Wealth Advisors Inc. now owns 404 shares of the company’s stock valued at $32,000 after buying an additional 146 shares during the period. Rise Advisors LLC bought a new stake in shares of Colgate-Palmolive during the first quarter worth $38,000. Continuum Advisory LLC lifted its stake in shares of Colgate-Palmolive by 46.5% during the second quarter. Continuum Advisory LLC now owns 394 shares of the company’s stock valued at $38,000 after acquiring an additional 125 shares during the period. Finally, Voisard Asset Management Group Inc. bought a new position in Colgate-Palmolive in the fourth quarter valued at about $40,000. Institutional investors and hedge funds own 80.41% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have issued reports on CL shares. HSBC restated a “hold” rating on shares of Colgate-Palmolive in a research report on Friday, July 26th. Hsbc Global Res cut shares of Colgate-Palmolive from a “strong-buy” rating to a “hold” rating in a research note on Friday, July 26th. TD Cowen upped their target price on shares of Colgate-Palmolive from $110.00 to $115.00 and gave the company a “buy” rating in a research report on Tuesday, July 30th. UBS Group increased their price target on Colgate-Palmolive from $119.00 to $122.00 and gave the company a “buy” rating in a research note on Wednesday, September 4th. Finally, Bank of America lifted their price objective on Colgate-Palmolive from $100.00 to $110.00 and gave the stock a “buy” rating in a research note on Wednesday, July 10th. One research analyst has rated the stock with a sell rating, eight have assigned a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat, Colgate-Palmolive has an average rating of “Moderate Buy” and a consensus target price of $102.79.

Get Our Latest Report on CL

Colgate-Palmolive Stock Up 1.0 %

CL stock opened at $103.06 on Friday. The business has a 50-day moving average of $102.71 and a 200-day moving average of $95.83. Colgate-Palmolive has a fifty-two week low of $67.62 and a fifty-two week high of $109.30. The stock has a market capitalization of $84.55 billion, a P/E ratio of 32.61, a P/E/G ratio of 3.72 and a beta of 0.40. The company has a debt-to-equity ratio of 16.90, a current ratio of 1.06 and a quick ratio of 0.70.

Colgate-Palmolive (NYSE:CLGet Free Report) last issued its quarterly earnings results on Friday, July 26th. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.87 by $0.04. The company had revenue of $5.06 billion during the quarter, compared to analysts’ expectations of $5 billion. Colgate-Palmolive had a net margin of 14.21% and a return on equity of 470.19%. The business’s quarterly revenue was up 4.9% on a year-over-year basis. During the same period last year, the business earned $0.77 EPS. On average, sell-side analysts anticipate that Colgate-Palmolive will post 3.57 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be given a dividend of $0.50 per share. The ex-dividend date is Friday, October 18th. This represents a $2.00 annualized dividend and a yield of 1.94%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 63.29%.

Insider Transactions at Colgate-Palmolive

In related news, insider Sally Massey sold 15,850 shares of the company’s stock in a transaction dated Tuesday, August 6th. The stock was sold at an average price of $103.28, for a total transaction of $1,636,988.00. Following the sale, the insider now owns 13,942 shares in the company, valued at $1,439,929.76. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, insider Sally Massey sold 15,850 shares of the firm’s stock in a transaction on Tuesday, August 6th. The shares were sold at an average price of $103.28, for a total value of $1,636,988.00. Following the completion of the transaction, the insider now directly owns 13,942 shares of the company’s stock, valued at $1,439,929.76. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Martina Hundmejean sold 2,313 shares of the company’s stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total transaction of $240,228.18. Following the sale, the director now directly owns 11,755 shares in the company, valued at $1,220,874.30. The disclosure for this sale can be found here. Insiders sold a total of 43,490 shares of company stock worth $4,486,063 in the last three months. Insiders own 0.34% of the company’s stock.

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Read More

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.